biobank
Building an Effective Informatics System at UK Biobank - An Interview with James Brennan
February 13 by Gerald ClarkeMost people understand that one of the greatest challenges with new technology or processes is getting them to integrate with existing systems. We spoke with James Brennan, Informatics Lead at the U...
Sample Quality and Integrity: Is Standardisation an Achievable Goal or a Dream?
December 05 by Pharmaceuticals & Biotechnology EditorIn this presentation Dr. Hagen von Briesen, Head of Department, Fraunhofer Institut fuer Biomedizinische Technik (IBMT), shares his insights on: What standards are required and can these standa...
Survey: Biobanking Industry Survey 2012
April 27 by Pharma IQ SurveysIn preparation for the 5th Annual Global Biobanking and Biorepository Forum 2012 taking place in September, I would like to invite you to take part in a short survey. The survey consists of no more...
Building a Better Biobank- Investing in the Future
April 16 by Pharmaceuticals & Biotechnology EditorThe biobanking landscape is changing rapidly to deal with the increasing demands of the systems biology community. The UK Biobank highlights the continuing advances in the research field with the...
Consent Critical to Building Public Support for Biobanks?
August 04 by Pharma IQEver-increasing demand for personalised medicine has enhanced the global requirement for biobanks to provide human tissue, body fluids and their derivatives. Between the two distinct types of bio...
An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals Chapter 3 - Biobanking
May 05 by Pharmaceuticals & Biotechnology EditorDeveloping Strategies and Tactics for Biobanking in a Healthcare System
January 12 by Andrea CharlesDr. Walter Stewart, Associate Chief Research Officer at Geisinger Center for Health Research, joins Andrea Charles from Pharma IQ, to discuss how biobanking can be leveraged to improve healthca...
Biobanking Grows in Scale
October 07 by Pharma IQThere has been a steady flow of new biobanks and virtual biocollections over the past few years and sizes of efforts and collections are growing. However, biobanking presents a range of...
High Throughput Screening Lessons Learnt: How Biobanking Can Benefit?
July 19 by Pharma IQMark Divers is the head of the Karolinska Institute’s biobank project in Sweden. He talks us through some of the key concerns before his seminar at this year’s conference. To listen to t...
UK Leads European Biobank Progress
July 19 by Pharma IQThe UK Biobank has smashed its initial target of filing the DNA of 500,000 adults aged 40-69, in what is seen as being the most comprehensive health study in the nation’s history. The proje...
Converting Problems into Opportunities When Building Up a Biobank
July 15 by Pharma IQPharma IQ is joined by Mark Divers, Executive Director, KI Biobank at Karolinska Institute, to discuss some of the prevalent aspects in the growing field of biobanking, from international partner...
The Secrets to Collaborative Success in Biobanking and Other Tips
April 18 by Frans van der HorstDr. Frans van der Horst, of Stichting Dutch Collaborative Biobank, joins Pharma IQ to discuss global biobanking. Pharma IQ: Frans, one of the key themes for Global Biobanking 2011 is collaboratio...